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Abstract
Introduction: Hyperglycemia is the main cause of diabetic complications, con-
tributing to a widespread degeneration of the nervous system. Nevertheless, the
main focus has been the sensory neurons because of neuropathic pain, while
the impairments associated with the spinal cord and motor deficits, mostly of
those initiated at early stages of the disease, have been poorly investigated. In
this way, the present study used the nonobese diabetic mouse model to evaluate
the microenvironment around motoneurons at ventral horn of the spinal cord,
following prolonged hyperglycemia. Methods: Adult female mice were divided
into two groups: spontaneously diabetic (n = 33) and nondiabetic (n = 26).
Mice were considered hyperglycemic when blood glucose surpassed 400 mg/dL.
Following 2 weeks from that stage, part of the animals was euthanized and the
lumbar intumescences were obtained and processed for immunohistochemistry
and transmission electron microscopy. For immunohistochemistry, the antibod-
ies used for integrated density of pixels quantification were anti-synaptophysin,
anti-GFAP, and anti-Iba1. The functional analysis was monitored with the
walking track test (CatWalk system) during 4 weeks. Results: The results
revealed significant motor impairment in diabetic animals in comparison to the
control group. Such loss of motor control correlated with a significant reduc-
tion in presynaptic terminals apposed to the motoneurons. Nevertheless, there
were no significant changes in glial reaction in the spinal cord. Conclusion:
Overall, the results herein revealed central nervous system changes at early
stages of the disease that may in turn contribute to the motor deficit. Such
changes open a new window of investigation in early stages of diabetes to better
comprehend motor impairment as a long-term complication of the disease.
Introduction
Diabetes mellitus (DM) is the most common metabolic
disorder in humans (Beauquis et al. 2008) involving a
group of related diseases characterized by hyperglycemia
as a result of insufficient insulin secretion, insulin
resistance, or both (Gispen and Biessels 2000). The
long-term complications of the disease affect the visual
system, kidneys, heart, and blood vessels (Beauquis
et al. 2008; Oliveira et al. 2013; Sato et al. 2014). More-
over, the nervous system is also affected leading to
complications at the CNS (central nervous system) and
PNS (peripheral nervous system) levels (Zochodne et al.
2008). Importantly, both insulin and its receptor are
present in the CNS (Gispen and Biessels 2000;
Zochodne et al. 2008), and play a modulatory role in
synaptic transmission and plasticity (Gispen and Biessels
2000; Northam et al. 2009; Jones 2012). It has been
reported that diabetes may affect neurotransmitter path-
ways (Northam et al. 2009), damaging nerves and
affecting cognition (Gispen and Biessels 2000; Jones
2012). Constant hyperglycemia may also affect the
blood–brain barrier function (Northam et al. 2009).
Sympathetic nervous system is also affected, leading to
ª 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
Brain and Behavior, doi: 10.1002/brb3.372 (1 of 9)
swollen axons and dendrites in a diabetes model (Sch-
midt et al. 2003).
It is reported that approximately 50% of diabetic
patients develop peripheral neuropathy or damage to the
PNS (Zochodne et al. 2008). Such impairments could be
only partially prevented with intensive insulin treatment
(Gispen and Biessels 2000), which has been reported to
increase the risk of dementia following chronic use due to
the alterations in metabolic pathways at the CNS (Jones
2012). In more severe cases, at latter stages of diabetes,
patients develop polyneuropathy, that is associated with
limb numbness, insensitivity to injury, which leads to
foot ulceration and amputation, allodynia, and severe
intractable pain (Zochodne et al. 2008; Talbot et al. 2010;
Francis et al. 2011). Motor incoordination has also been
linked to constant falling in type 2 diabetes (Schwartz
et al. 2008).
Although much is known about metabolic diabetic
complications, the impairments within the CNS, mainly
at the spinal cord, affecting motor pathways have been
relatively little studied. The primary clinical problems are
almost exclusively centered on the neuropathic pain and
loss of sensation (Zochodne et al. 2008), lacking a focus
on the motor component, which may contribute for
motor impairment as a long-term complication of the
disease.
Considering this scenario, the NOD (nonobese
diabetic) mouse is a useful tool for studying DM1 (type 1
diabetes mellitus), because it undergoes autoimmune
spontaneous b-cell degeneration (Saravia and Homo-
Delarche 2003; Schmidt et al. 2003), with clinical and
pathophysiological features suitable to precede transla-
tional human studies (Schmidt et al. 2003). In this way,
the better understanding of morphological and functional
changes, at the ventral horn of the spinal cord, during the
initial stages of high hyperglycemia may help the develop-
ment of better neuroprotective strategies to ameliorate
the CNS degeneration during the course of the disease.
Due to all of alterations previously described, and consid-
ering there is still lack of comprehension of how such
impairments are caused and affect motor control, we
aimed to investigate glial and synaptic changes at the
ventral horn of spinal cord and its correlation to motor
alterations during the course of hyperglycemia.
Materials and Methods
Animals
Fifty-nine adult female NOD/Uni mice (4 weeks old)
were obtained from the Multidisciplinary Center for
Biological Investigation (CEMIB/UNICAMP) and housed
under a 12-h light/dark cycle with free access to food and
water. The study was approved by the Institutional Com-
mittee for Ethics in Animal Use (CEUA/IB/UNICAMP,
prot. no. 1636-2). The glycemia was monitored twice a
week from the fourth week of age. Measurements were
carried out by mid-morning, and the animals were not
fasted before the glucose level was measured. Mice were
considered hyperglycemic when blood glucose surpassed
400 mg/dL, event that occurred at the age of 21–25 weeks
(25 g body weight). Control mice presented glucose levels
up to 150 mg/dL. In the present study, mice which devel-
oped diabetes were kept alive for two additional weeks,
without any treatment (diabetic group) for immunohisto-
chemistry and TEM (transmission electron microscopy).
Age-matched nondiabetic siblings were used as the con-
trol group as described previously (Schmidt et al. 2003).
For the gait parameter analysis (CatWalk system, Noldus,
the Netherlands), siblings and diabetic animals were
monitored twice a week for 30 days after the onset of the
disease. The number of animals used for each technique
is described in Table 1.
Diabetes and glycemic control
The blood glucose concentration samples were obtained
from the tail vein and measured by a strip-operated blood
glucose sensor (Accu-Chek Performa; Roche, S~ao Paulo,
Brazil). The glucose concentration in blood serum was in
the range of 100–165 mg/dL for control animals, and
>400 mg/dL for diabetic animals, at the beginning of the
experiment. Fifteen days later, the control animals main-
tained the glycemia at around 100 mg/dL as previously
measured, but the diabetic mice presented increased val-
ues (over 600 mg/dL), as reported elsewhere (Schmidt
et al. 2003). It was not possible to measure glucose levels
above it, as this was the limit of the device scale. Figure 1
shows the blood glucose concentration of animals during
the experiments. Diabetic mice demonstrated typical
symptoms of diabetes including polydipsia and polyuria.
Table 1. Number of animals used throughout the study, detailed per
technical procedure.
Technical procedure Control Diabetic
Immunohistochemistry
synaptophysin
5 9
Immunohistochemistry glial
fibrillary acidic protein
9 11
Immunohistochemistry ionized
calcium-binding adapter
5 5
Transmission electron microscopy 4 5
CatWalk 3 3
Total number per group 26 33
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Immunohistochemistry for anti-
synaptophysin, anti-GFAP, and anti-Iba1
After the predetermined survival period, the animals were
anesthetized with a mixture of Kensol (xylasin; 10 mg/kg)
and Vetaset (ketamine; 50 mg/kg), and the vascular
system was rinsed by transcardial perfusion with PBS
(phosphate-buffered saline, pH 7.4). For the immunohis-
tochemical detection, the animals were fixed by vascular
perfusion with 4% formaldehyde in PBS. The lumbar
intumescence from each animal was dissected out, post
fixed overnight in the same fixative, washed in PBS, and
stored in sucrose (20%) for 8 h before freezing. Cryostat
transverse sections (12-lm thick) of the spinal cords were
obtained and transferred to gelatin coated slides, dried at
room temperature for 30 min, and stored at –21°C until
use. The sections were washed three times in PBS and
blocked with 3% BSA (bovine serum albumin) in PBS
plus 0.2% Tween for 1 h. Primary antibodies are detailed
in Table 2. The primary antibodies were diluted in a
solution containing 1% BSA in PBS and Tween 9100. All
sections were incubated overnight at 4°C in a moist cham-
ber. After washing with PBS, the sections were incubated
with the secondary antibody according to the primary host
antiserum (1:500; Cyanine Dyes CY-3, Jackson Immunore-
search, West Groove, PA) for 45 min in a moist chamber
at room temperature. The sections were then rinsed in
PBS, mounted in a mixture of glycerol/PBS (3:1), and
observed in a Nikon Eclipse TS100 inverted microscope
(Nikon, Tokyo, Japan). For quantitative measurements,
three representative images of each spinal cord were cap-
tured at a final magnification of 9200 with a CCD camera
(DXM1200i; Nikon) and the software Metamorph 6.3
(Meta Imaging Series; Molecular Devices, Sunnyvale, CA).
Immunolabeling pattern of the antibodies used in this
work were similar to that observed in other studies (Perez
et al. 2013; Spejo et al. 2013). For quantitative measure-
ments, three alternate sections from the same level of the
spinal cord (just the right side was chosen for standardiza-
tion) from each animal (n = 5 for diabetic group and
n = 4 for control group) were used to capture images
from the ventral horn at a final magnification of 9200,
always using identical settings. Quantification was per-
formed with the enhance contrast and density slicing fea-
ture of ImageJ software (version 1.33; National Institutes
of Health, Bethesda, MD). In this way, the threshold of
each image was manually obtained by comparison with
the initially captured images. For synaptophysin immuno-
labeling, the integrated density of pixels was systematically
measured in eight representative areas around each motor
neuron dorsolateral lamina IX using a circular sampling
area as described previously (Oliveira et al. 2004; Barbizan
and Oliveira 2010; De Freria et al. 2012; Freria et al. 2012;
Perez et al. 2013; Spejo et al. 2013; for specific review of
the method please check supplementary material of Freria
et al. 2012). For the analysis of anti-GFAP and anti-Iba1
antibodies, the integrated density of pixels was measured
in the whole picture in the lateral region of the spinal cord
at the ventral horn as reported in a previous work (Perez
et al. 2013). The integrated pixel density was calculated
for each section and then as a mean value for each spinal
cord. The data are represented as mean  SE (standard
error).
Transmission electron microscopy
For TEM, 100 mL of a fixative containing 2.5% glu-
taraldehyde and 0.5% paraformaldehyde in PBS was per-
fused through the ascending aorta. The lumbar spinal
cords were removed and stored overnight in the same fix-
ative at 4°C. The specimens were then trimmed and
osmicated, dehydrated, and embedded in Durcupan ACS
(Fluka, Steinheim, Switzerland). Ultrathin sections
(60 nm thick) from the L4–L6 segments were collected
on formvar-coated copper grids, and then contrasted with
Figure 1. Blood glucose concentration of control (n = 7) and diabetic
(n = 5) animals from the detection of hyperglycemia until euthanasia
for morphological evaluation.
Table 2. Primary antibodies used for immunohistochemistry.
Antibody
Manufacturer/
Cat. no. Anti-IGG
Mono- or
polyclonal
Synaptophysin DakoCytomation/
M0776
Mouse Monoclonal
Glial fibrillary
acidic protein
Abcam7779 Rabbit Polyclonal
Ionized calcium-
binding adaptor
protein
Wako/019-19741 Rabbit Polyclonal
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uranyl acetate and lead citrate, and examined under a Leo
906 transmission electron microscope operating at 60 kV.
Neurons with large cell bodies found in the sciatic
motoneuron pool of spinal cord were identified as alpha
motoneurons by the presence of C-type nerve terminals
(Barbizan and Oliveira 2010; De Freria et al. 2012; Freria
et al. 2012). The surface of the cells were then sequentially
digitized at a magnification of 911,300 by using a video
camera connected to a computerized system, plus the
acquisition feature of the Kontron KS300 software (Zeiss,
Jena, Germany). The images were then mounted together
using the Adobe Photoshop software (Adobe Systems Soft-
ware Ireland Ltd., Ireland), and the total perimeter of the
neurons was measured. Synaptic terminals apposing the
motoneuron somata were identified, and their numbers per
100 lm of cell membrane was calculated by using the mea-
surement tool of the Image Tool software (version 3.0; The
University of Texas Health Center at Santo Antonio, TX).
The terminals were typed as F (with flattened synaptic vesi-
cles, inhibitory inputs), S (with spherical synaptic vesicles,
excitatory inputs), or C (cholinergic inputs) according to
the nomenclature of Conradi (1969). In total, two neurons
per animal in each group were analyzed (n = 5 for diabetic
and n = 4 for control) according to previous publications
(Oliveira et al. 2004; Barbizan and Oliveira 2010; De Freria
et al. 2012). The values are shown as a mean  SE.
Walking track test
In the walking track test (CatWalk system; Noldus Inc.,
Wageningen, the Netherlands), the animal crosses a walk-
way with an illuminated glass floor. A high-speed video
camera Gevicam (GP-3360; GEViCAM Inc., Milpitas, CA)
equipped with a wide-angle lens (6.0 mm; DF6HA-1B, Fuji-
non Corp., China) is positioned underneath the walkway
and the paw prints are automatically recorded and classi-
fied by the software as the animal moves across the path-
way. The measurements were recorded every 3 days for a
month, after the detection of diabetes, in the diabetic
group. Control group was analyzed in parallel to the hyper-
glycemic group. Motor function was analyzed for 30 days
following hyperglycemia was detected, using the base of
support (the average width between the paws), stride length
(the distance between successive placements of the paw),
and maximum intensity at (%) (the time in seconds since
the start of the run that the largest part of the print makes
contact with the glass plate, relative to the total duration of
contact) of the hind paws parameters of CatWalk system.
Statistical analysis
The data were analyzed by one-way (immunohistochem-
istry and TEM) and two-way (walking track test) analysis
of variance (ANOVA). P < 0.05 (*), P < 0.01 (**), and
P < 0.001 (***) were considered statistically significant.
Results
DM1 triggers synaptic changes around
motoneurons
Significant synaptic density decrease was detected in the
diabetic mice as seen by anti-synaptophysin labeling
(P < 0.05) (Fig. 2A, D, and G, control 54,210  2490
n = 5 and diabetic 39,540  3475 n = 9). Such finding is
consistent with the TEM evaluation that allows a fine
observation of the surface of the spinal motoneurons. In
this sense, a decrease in F terminal covering in apposition
to the motoneuron somata (Fig. 3C, control – 46.18 
1.35%, n = 4; diabetic – 28.08  1.76%, n = 5; P <
0.001) was found, indicating a significant reduction of
putative inhibitory inputs to alpha motoneurons. On the
contrary, no statistical change in S terminal apposition
was depicted (Fig. 3D, control – 13.88  1.86%, n = 4;
diabetic – 11.96  0.755%, n = 5), suggesting a possible
overall relative increase in excitation that may trigger exci-
totoxic events. No significant changes in cholinergic C
terminals (Fig. 3E, control – 2.688  0.552%, n = 4;
diabetic – 3.732  0.581%, n = 5) could be detected
during hyperglycemia.
Two weeks of hyperglycemia do not cause
significant changes in glial reaction
There was no significant increase in GFAP immunolabel-
ing in the diabetic mice as compared to the control group
(Fig. 2B, E, and H; control – 1.29 9 107  3.34 9 106,
n = 9; diabetic – 1.93 9 107  2.31 9 106, n = 11; inte-
grated density of pixels measured per picture area). The
same pattern was depicted for Iba1 immunostaining
(Fig. 2C, F, and I; control – 5.61 9 106  4.98 9 105,
n = 5; diabetic – 7.04 9 106  8.38 9 105, n = 5; inte-
grated density of pixels measured per picture area).
Diabetic mice develop motor impairments
at the initial stage of the disease
In order to access the effects of prolonged hyperglycemia
on the locomotor behavior we used the walking track test.
The evaluation was performed on the CatWalk system,
which provides accurate measurements of paw prints as
well as pressure during spontaneous locomotion. The
results revealed that maximum intensity at (%) and base
of support parameters were increased (P = 0.0161 and
P = 0.0451, respectively; Fig. 4A and B), while stride
length was decreased in diabetic mice (P = 0.0424)
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(Fig. 4C). Such results are consistent with the immuno-
histochemical findings regarding synaptic stripping; indi-
cating that hyperglycemia quickly affects motor skills,
possibly by harming spinal descending pathways as well
as local spinal cord networks.
Discussion
The present work reports important changes at the spinal
cord microenvironment during the initial course of DM1
and its correlation with motor coordination deficits, indi-
cating that synaptic changes occur soon after hyper-
glycemia is installed in diabetic individuals. The impact of
DM on CNS has already been related to learning and
memory problems. Such deficiencies are associated to vas-
cular dementia as well as Alzheimer’s disease. Also,
impairments in mental and motor responsiveness have
been proposed (Gispen and Biessels 2000), although how
such complications happen into the spinal cord are still
poorly understood.
Diabetes mellitus leads to damage of neurons, and
hampering regenerative capacity (Zochodne et al. 2008).
In this sense, a previous work reported that sensory neu-
rons are first affected, resulting in loss of skin innervation
(Zochodne et al. 2008). Later, sensory neurons undergo
atrophy and eventual degeneration. Contrarily to that,
although motoneurons are preserved, a loss of neuromus-
cular junctions takes place during the course of the
disease (Zochodne et al. 2008; Francis et al. 2011). It is
also reported that sympathetic neuritic dystrophy occurs
within 3–5 weeks after the onset of hyperglycemia
(Schmidt et al. 2003).
Most studies relating hyperglycemia and CNS degenera-
tion focused on neuronal and glial cells at the dorsal horn
(A) (B) (C)
(D) (E) (F)
(G) (H) (I)
Figure 2. Immunohistochemistry at lamina IX. (A, D) Synaptophysin. (B, E) GFAP (glial fibrillary acidic protein). (C, F) Iba1 (ionized calcium-binding
adapter molecule 1). (G–I) Quantification of the integrated density of pixels of synaptophysin, GFAP, and Iba1, respectively. *P < 0.05.
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of the spinal cord (Wang et al. 2007; Talbot et al. 2010;
Chen et al. 2011; Crown 2012; Dauch et al. 2012). On the
contrary, there is a lack of publications aiming at under-
standing changes in the ventral horn. Thus, motoneurons
have not been widely considered among the primary tar-
gets of DM and, although they have been suspected to be
less susceptible to diabetic polyneuropathy, this has not
been validated in any experimental system (Zochodne
et al. 2008). In this respect, the present work shows con-
siderable changes within motoneuron microenvironment
after 2 weeks of hyperglycemia.
Spinal cord is a complex part of the CNS containing
glial cells and neurons. Such neurons convey supraspinal
inputs to the periphery as well as transmit afferent inputs,
thus coordinating the flow of information regarding sen-
sation and limb movement. It is known that the spinal
dorsal horn is a critical site for the transmission and
modulation of nociception, receiving glutamatergic inputs
from primary afferents and local interneurons (Chen
et al. 2011). In this sense, it is known that an increase in
glutamatergic inputs into the dorsal horn of the spinal
cord occur in diabetic rats (Wang et al. 2007; Chen et al.
2011). Therefore, there is an imbalance between excitatory
and inhibitory inputs at the dorsal horn, which might
contribute to neuropathic pain. It also may trigger an
imbalance of inputs in other areas of the spinal cord as
well, such as the ventral horn. It is important to empha-
size that most of the glutamatergic input to the motoneu-
rons arises from dorsal root ganglia sensory neurons,
which are vesicular glutamate transporter 1 positive. In a
previous study, the section of dorsal roots was able to
deplete near to all glutamatergic synapses in the ventral
horn (Oliveira et al. 2003). In this way, alterations of
DRG neurons by hyperglycemia may directly affect spinal
motoneuron inputs, generating the abovementioned input
imbalance.
Based on the consequences mentioned above, associ-
ated with metabolic complications of the diabetes, such
as motor and sensory nerve conduction deficits (Obro-
sova et al. 2005), it is feasible to suggest that hyper-
glycemia also affects the ventral horn microenvironment.
Such changes include significant loss of inhibitory termi-
nals in apposition to motoneuron cell bodies, as seen by
synaptophysin immunolabeling and TEM. Our work is
consistent with previous data, in which reduction in
synaptophysin immunolabeling was depicted 20 weeks
after the onset of the disease (Jiang et al. 2010). We sug-
gest that such changes occur much sooner than expected.
(A)
(B)
(C)
(D)
(E) Figure 3. Transmission electron
microscopy analysis. (A) Representative
image of F terminals (orange) and S
terminals (blue) obtained from a control
specimen. (B) Representative image of C
terminals (green) obtained from a control
specimen. (C–E) Graphs of the number of
F, S, and C terminals per 100 lm of cell
membrane of the motoneuron.
***P < 0.001.
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Such immediate changes may contribute to generating an
imbalance between excitatory and inhibitory inputs, con-
tributing to motor control impairment and gait alter-
ations, as seen herein.
Additionally to loss of synapses, the close relation
between astrocytes and the blood–brain barrier makes them
early sensors for variations in glucose homeostasis. It has
been already shown activation of such cells in the
hippocampus (Beauquis et al. 2008) and at the spinal cord
in a type 2 DM model (Liao et al. 2011; Dauch et al. 2012;
Ren et al. 2012). On the other hand, it has also been
reported a reduction in GFAP immunolabeling at the spinal
cord following the course of the disease (Afsari et al. 2008).
Our results showed no statistical upregulation of GFAP,
although there is a trend of increasing. Also, microglial
activation was present in the diabetic material, although no
statistical differences in comparison to the control mice
could be obtained at such early stage of the disease. It has
already been shown that microglia activation occurs at the
dorsal horn of spinal cord at early stages of diabetes (Talbot
et al. 2010) and it is widely related with the development of
neuropathic pain (Wodarski et al. 2009; Talbot et al. 2010;
Wang et al. 2014). Although we were unable to find statisti-
cal increase of glial reaction at such early stage of the dis-
ease, it is possible that the trend of gliosis become
significant at later survival times, even in the ventral horn.
This may be investigated in future follow-up studies.
Despite no significant changes in glial cells, the pres-
ence of early changes in the synaptic terminals around
motoneurons, following 2 weeks of hyperglycemia, is of
great relevance, since motoneurons constitute a nucleus
of integration of a variety of sensory and motor informa-
tion toward and from the PNS. Motoneurons play a criti-
cal role in coordinating muscle fibers for accurate
movement. In humans, the presence of high glucose
plasma levels lead to peripheral neuropathy at later stages,
which is associated with a decline in the motor com-
pound action potential, unstable neuromuscular junction,
and abnormal foot positioning, associated with altered
distribution of plantar pressure during standing or walk-
ing (Zochodne et al. 2008). Nevertheless, patients do not
report progressive and widespread muscle weakness as
observed in motoneuron diseases, such as ALS (Zochodne
et al. 2008). Locomotor impairments could be the
summation of different factors such as oxidative stress
(Obrosova et al. 2005; Zochodne et al. 2008), distur-
bances in axonal conduction (Gispen and Biessels 2000),
slowing of axonal conduction velocity (Gispen and Bies-
sels 2000; Obrosova et al. 2005), vascular dysfunction,
reduced nerve blood flow (Gispen and Biessels 2000;
Zochodne et al. 2008), and alterations in trophic support
which might contribute to metabolic changes in the
motoneurons. It is also reported that the responsiveness
to acute pain is reduced in NOD diabetic mice (Obrosova
et al. 2005). Altogether such factors may contribute to the
imbalance between excitatory and inhibitory inputs at the
motoneuron cell body, as shown in the present work,
contributing to the significantly decreased performance in
comparison to the control counterpart.
An additional novelty of the present work is the use of
the CatWalk system as an automatized gait acquisition
apparatus for diabetes studies. Such system has been
(A)
(B)
(C)
Figure 4. Walking track test carried out using the CatWalk system
(Noldus Inc., Holland). (A) Base of support. (B) Maximum intensity at
(%). (C) Stride length (mm). *P < 0.05.
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widely used to report functional impairments due to
peripheral nerve lesion, spinal cord lesion, root transec-
tion, and neurodegenerative diseases. Nevertheless, the
evaluation of motor disturbances as a result of DM1 has
not been reported previously with this approach. The
maximum contact at (%) parameter is reported as
increased and the base of support parameter is also
affected after spinal cord injury (Hamers et al. 2001), and
it is also altered in diabetic mice, indicating important
changes in the motor circuitry. Overall, the walking track
test provided accurate motor control and coordination
analysis during the course of early diabetes, and the
results were compatible to previous studies investigating
spinal cord injury, neurodegenerative diseases, peripheral
nerve injury, and corticospinal tract damage (Starkey
et al. 2005; Deumens et al. 2007; Chuang et al. 2010;
Figley et al. 2014). Nevertheless, evaluation of greater
number of subjects at different stages of the disease as
well as additional gait parameters may provide further
details and reinforce the findings described herein.
Conclusion
The present study brings new early effects of DM1 within
the spinal cord at the ventral horn and its correlation
with motor impairments. Such findings reinforce the pos-
sible correlation between synaptic changes and motor
complications, providing a new perspective regarding
presynaptic input retraction from motoneuron surface as
the result of early installed hyperglycemia.
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